Rs1347093 regulates microRNA-216/-217 expression and is associated with pancreatic cancer risk
Authors:
- 2 October 2024
- journal article
- research article
- Published by Elsevier in Pancreatology
- Vol. 24 (8) , 1294-1301
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- LncRNA SNHG20 promotes cell proliferation and invasion by suppressing miR-217 in ovarian cancerGenes & Genomics, 2021
- LncRNA KCNQ1OT1 acts as miR-216b-5p sponge to promote colorectal cancer progression via up-regulating ZNF146Journal of Molecular Histology, 2021
- LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1Journal of Surgical Research, 2021
- Therapeutic targeting of miRNA-216b in cancerCancer Letters, 2020
- RAD21 inhibited transcription of tumor suppressor MIR4697HG and led to glioma tumorigenesisBiomedicine & Pharmacotherapy, 2020
- Cluster miRNAs and cancer: Diagnostic, prognostic and therapeutic opportunitiesWIREs RNA, 2019
- A polymorphism in miR‐1262 regulatory region confers the risk of lung cancer in Chinese populationInternational Journal of Cancer, 2017
- Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated With Estrogen Receptor-Negative Subtypes and Poor PrognosisEBioMedicine, 2015
- Hsa-miR-499 polymorphism (rs3746444) and cancer risk: A meta-analysis of 17 case–control studiesGene, 2012
- Common genetic polymorphisms in pre-microRNAs were associated with increased risk of dilated cardiomyopathyClinica Chimica Acta, 2010